Tower Research Capital LLC (Trc) Ionis Pharmaceuticals Inc Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 14,157 shares of IONS stock, worth $439,433. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,157
Previous 4,301
229.16%
Holding current value
$439,433
Previous $172,000
187.21%
% of portfolio
0.01%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding IONS
# of Institutions
416Shares Held
140MCall Options Held
861KPut Options Held
714K-
Vanguard Group Inc Valley Forge, PA16.5MShares$511 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$440 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$356 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$320 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$269 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.41B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...